Early Pregnancy Flashcards

1
Q

Definition of a miscarriage

A

TVS: MSD > 20mm w no FP
FP > 7mm w no FH

TAS: MSD >25mm w no FP
FP >8mm w no FH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Difference between complete and incomplete miscarriage

A

ETT <15 = complete, >15mm =incomplete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PUV vs PUL

A

PUV: MGSD </=20mm, no FP OR FP <7mm w no FH
PUL no IUGS seen OR IUGSw no YS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of miscarriage

A

Conservative - rpt USS 2/52
Medical: 80=91% effective. Mife 200mcg+ miso 800mcgx 2, rpt USS 2/52. ADRS: N&V, diarrhoea, PVB. Admit if MGSD >50mm
Surgical: ERPC, PT 2/52 later, Anti-D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for recurrent miscarriage

A

Maternal age
Smoking
Caffeine
ETOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of recurrent miscarriage

A

ChAII TEA
Chromosomal - parental rearrangements + embryonic abnormalities
Antiphospholipidsyndrome
Immune
Infective
Thrombophilia
Endocrine
Anatomical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Role & effect of antiphospholipid syndrome

A

Includes lupus anticoagulant, antiB2 gylcoprotein ab, anticardiolipin abb
Adverse outcomes: early pregnancy loss, MTL, PTB
Inhibits trophoblastic function and differentiation. Activates complement pathways at mat/fet interface –> inflammatory response; thrombosis of uteroplacental vasculature in later pregnancy
Effects reversed with LMWH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis of ectopic pregnancy

A

Serial HCG measurement
TAS/ TVS:
No IUGS + YS
60% homogenous adnexal mass adjacent to ovary
20% hypoechoic ring/ bagel sign
13% GS+FP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of ectopics

A

Tubal - bagel sign/ homogenous adnexal mass
Cervical - empty uterus, barrel-shaped cervix, GS below level of internal os, absence of sliding sign
Scar - GS low in uterine cavity. MRI 2nd line
Interstitial - empty uterine cavity, POC/GS in intramural part of tube + surrounded by <5mm myometrium
Cornual - visualisation of single interstitial portion of fallopian tube in main uterine body, GS/ POC seen mobile and separate fro uterus + completely surrounded by myometrium + vascular pedicle adjoining GS to unicornuate uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MTX candidate

A
  • haemodynamically stable
  • low HCG, ideally <1500 (NICE 1500-5000)
  • No FH
  • certainty of no viable IUP
  • willingness to attend for F/U
  • no known sensitivity to MTX
    NICE:
  • no significant pain
  • unruptured, w mass <35mm and no visible FH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

R/F for ectopic pregnancy

A
  • infertility (x2)
  • tubal pathology (x3)
  • documented salpingitis (x4)
  • prev TL ( 1/3)
  • pregnancy w IUCD (1/2)
  • prev ectopic( 1 prev - >10%, 2 prev >25%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MTX MOA & mx plan

A

MOA : Folic acid antagonist –> inhibits RNA & DNA synthesis by deactivating dihydrofolate reductase
Dose : 1mg/kg
HCG D0, D4 & D7
Monitor LFTs (hepatotoxic)
If decrease <15%, rpt MTX dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

USS appearance molar pregnancy

A

Complete: snowstorm appearance, no embryo, bilateral thecal cystrs
Partial: embryo, cystic spaces in placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pre-op management molar pregnancy

A

Ix: FBC, LFTs, U&E, CXR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

F/U post molar pregnancy

A

Evacuation (12mm catheter) + anti-D if required

Monitor serum hcg weekly until normalised x 3/52

Normalisation <8/52 —> monitor for 6/12post ERPC

Normalisation > 8/52 –> monitor for 6/12 post normalisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complete vs partial molar pregnancy

A

Complete: diploid empty ovum ( 2x sperm); uniparental disomy
Partial: triploid (1x ovum, 2x sperm)

17
Q

Treatment - choriocarcinoma - indications

A
  • plateau or increasing bhcg
  • heavy PVB
  • mets
  • chorio on histo
  • bhcg >/= 20000
  • increase bhcg at 6/12 post ERPC
18
Q

Investigations of patients with GTN

A

Pelvic USS
CXR and CT A-P
–> normal –> no further radiological ix
—> metastases –> CT chest, MRI brain

19
Q

Symptoms of invasive choriocarcinoma & Mx

A

Sx: dyspnoea, haemoptysis, seizures
Ix: TFTs, hcg, U&E, LFT, FBC, CXR, CT TAP w MRI brain if lesions >2mm, USS abdo pelvis
If suspicious, run bhcg
ERPC –> histo diagnosis
Refer to GTD centre
Chemo required: complete - 15%, partial 0.5-1%
No anti-D required if complete (no fetal cells)

20
Q

Features of hyperemesis

A

Weight loss
Ketonuria
Electrolyte imbalance/ dehydration
Vitamin and mineral deficiency
thyroid/ renal/ hepatic impairment

21
Q

Main vitamin deficiency in HG and rx

A

Thiamine deficiency (vitamin B1) –> Wernicke’s encephalopathy –> irreversible neuro impairment
Rx w IV pabrinex (contains thiamine hydrochloride, riboflavin, pyridoxine
hydrochloride and nicotinamide (B vitamins); ascorbic acid (vitamin C); and glucose)

22
Q

HG presents as a complication of which conditions

A
  • UTI
  • multiple pregnancy
  • GI conditions
  • Neuro conditions
  • Molar preg
  • endocrine - addisons, hypercalcaemia, uraemia, TFT
  • Psych conditions
23
Q

Assessment tool for HG

A

PUQE score:
- /15
- 3 Q’s: how often nauseated, how many times vomited, how many times dry wretched
Aims to guide clinical decision making

24
Q

Definition and management of severe HG

A

PUQE >/= 13
Ketonuria
Clinically dehydrated

Mx:
Admit
Cariban
Promethazine / prochlorperazine (po/ IM/ buccal) / cyclizine
IV fluids
Pabrinex
COnsider potassium replacement
No improvement: consider mteoclopramide
No improvement: consider ondansetron or hydrocortisone

25
Q

Section 12 TOP act

A

<12/40 for maternal choice (from LMP)
Primary: <9+6, 48 hour cool off period
- mife + miso, low sensitivity PT 2/52 later
- last day to be given D69
If unsure of dates –> USS
>9/40 - hospital mTOP, 2 consultant sign off
Hospital - if failed MTOP, unsure of dates, R/O ectopic
12/40 = 63mm

26
Q

Section 11 TOP act

A

Fatal fetal anomalies
2-3% pregnancies have congenital anomalies
— 15% fatal/ life-limiting
Fetal med referral
Feticide can be performed no ensure no signs of life at delivery
Indications include: B/L renal agenesis, severe skeletal dysplasia, anencephaly, T13, T18, hydrancephaly

27
Q

Section 9 & 10 TOP act

A

Pertain to risk of life/ health of pregnant woman
- 2 consultants to assess pt
- women w mental health diagnoses/ medical diagnoses should have priority access

28
Q

RCOG TOP guidelines

A

Cannot be reversed: <3% ongoing pregnancies, r/o congenital malformation 4.2%
No need for USS if approp tissue passed
If little/ no bleeding - r/o ectopic
Haemodynamic instability - ERPC
Offer LARC

29
Q

TOP treatment algorithm - first trimester mTOP

A

Mife in clinic and admitted >24 hours to ward to commence med mx
- 800mcg buccal miso stat, then 400mcg 3 hourly x 4 doses
Pregnancy tissue passed –> visually inspect –> complete + no concern re GTD –> discharge
No pregnancy tissue passed –> obstetrics review : ensure stable vitals, confirm correct administration of meds, US if uncertainty re all pregnancy tissue passed
–> repeat medical regimen (400mcg buccal miso 3 hourly x 5doses)
- OR sTOP
if no pregnancy tissue passed after second round medical management –> sTOP

30
Q

Complications TOP

A

Medication side effects: N&V, heavy bleeding, abdo pain
Treatment failure - repeat mTOP/ sTOP
Infection - rx w broad spectrum Abx
sTOP complications: bleeding, perforation, cervical laceration

31
Q

Management algorithm: acute haemorrhage following TOP

A

HISTORY
- LMP
- when were mife/ miso taken
- duration of bleeding/ how much blood loss
- ? passage of pregnancy tissue
- ? discharge/ abdo pain
- ? previous uterine surgery
- PMHx
EXAM
- vitals/ abdo/ bimanual/ sse
UNSTABLE PT
- call for help - senior obstetrician/ anaesthetics
- ABCs
- 2x 14G IVC, FBC, LFT, U&E, CRP, coag, GXM, VBG
- IV fluids, high flow O2, UC, blood products
- T/F to theatre

32
Q

Management ongoing/ incomplete termination (rx algorithm) in acute haemorrhage

A
  • FBC, U&E, LFT, CRP, GXM
  • Consider theatre - ERPC (T1), MROP (T2)
  • consider abx
  • bimanual compression
  • consider uterotonics: IM/ IV oxytocin/ IM syntometrine/ IM carboprost
  • consider IV TXA/ fibrinogen/ clotting factors
33
Q

Management infection in acute haemorrhage post TOP

A

FBC, U&E, LFT, CRP, GXM
HVS, MSU, +- blood cultures
IV broad spectrum antibiotics
Consider ultrasound to r/o RPOC

34
Q

Management uterine rupture in acute haemorrhage post TOP

A

FBC, U&E, LFT, CRP, GXM
Emergency laparotomy
Abx/ blood products

35
Q

Algorithm for investigations recurrent miscarriage

A

Detailed hx from woman + partner
After 2 consecutive losses:
- TFTs, thyroid antibodies (thyroid peroxidase, thyroglobulin), FBC, ANA, thrombophilia (APL- lupus anticoagulant, anticardiolipin ab, B2 glycoprotein 1), consider HBA1c, TVUS
If <35yo and 2 consecutive losses - perform cytogenetics. If no tissue for cytogenetics, perform parental karyotypes
If >35yo and 3 consecutive losses, cytogenetics. Karyotype if no tissue available for cytogenetics

36
Q

Modifiable risk factors for recurrent miscarriage

A

Smoking
BMI
Drugs
Alcohol
Diet (caffeine <200mg/d)
FA
Vit D

37
Q

Treatment for unexplained recurrent miscarriage

A

Progesterone PV 400mcg bd
Aspirin 75mg if at risk for placental insufficiency
Address modifiable risk factors

38
Q

Treatment for recurrent miscarriage by cause

A

Anatomy - reconstruction not recommended
Thombophilia (hereditary) - aspirin 75mg preconception and LMWH once PT +ve
Endocrine - rx hypothyroidism w eltroxin; progesterone 400mcg PV; hyperprolactinaemia - bromocriptine
Genetics - gamete donor, PIGT